Timothy K. Lu - 04 Feb 2025 Form 4 Insider Report for Senti Biosciences, Inc. (SNTI)

Signature
/s/ Robert Cutler, attorney-in-fact
Issuer symbol
SNTI
Transactions as of
04 Feb 2025
Net transactions value
-$18,339
Form type
4
Filing time
06 Feb 2025, 20:23:37 UTC
Previous filing
02 Feb 2024
Next filing
10 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNTI Common Stock Sale $15,963 -3,922 -4.5% $4.07 82,627 04 Feb 2025 Direct F1
transaction SNTI Common Stock Sale $2,376 -545 -0.66% $4.36 82,082 06 Feb 2025 Direct F1
holding SNTI Common Stock 52,839 04 Feb 2025 By spouse
holding SNTI Common Stock 52,839 04 Feb 2025 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
F2 The shares are held by Luminen Services, LLC, as trustee of the Luminen Trust, of which the reporting person is the settlor. The reporting person disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.

Remarks:

Exhibit 24 - Power of Attorney